shareholder movement update, page-20

Hi Sailfish

My guess is that one part of XTrade system has to reconcile with others (old fashion flat files) before an update can happen. It will show up eventually, unless someone sells down at 1.3c beforehand.

I have no other news except my monitoring still continues along with some thoughts of strategies and eventualities.

I note the word ""EXTENDED"" its out-licensing program in relation to its midkine cancer diagnostic assets." from the quarterly.

The licencees (Quest and Pacific Edge(PEB)) remain the same .... so I interpret the Quarterly as saying that additional licence(s) have been granted to one or both of these companies. My wild guess is that the additional licence(s) would be PEB based on gut feel alone as both companies have additional pipline products which (I expect) include midkine as a biomarker.

When will licenced used of CDY's IP gain commercial traction? The answer is when approval then acceptance happens in a major market such as the US. My guess is some time this year for Quest and next year for PEB {based on anns advising expected completion of PEB's US diagnostic labs in 2013).

I note the Aussie based manufacture of midkine and now evolis now in the pipeline. There maybe some planned tax incentives for both me thinks.

What I think matters not to anyone else (I guess) until the company provides guidance on finance. IMHO the La Jolla suicide bonds were dumped maybe 12 months early as we really needed to have the HU91 clinical trial ready PLUS some additional incoming licence and hair tonic revenue coming in first. Whatever ... my guess is that something else is in the wings but I know not what and La Jolla is still available if everything else goes turtle.

Some additional milestone results (in areas not covered by the quarterly) are now due by my reckoning. I can but wait.

cheers